Acceptability of exclusive breast-feeding with early cessation to prevent HIV transmission through breast milk, ANRS 1201/1202 Ditrame Plus, Abidjan, Côte d'Ivoire. by Becquet, Renaud et al.
Acceptability of exclusive breast-feeding with early
cessation to prevent HIV transmission through breast
milk, ANRS 1201/1202 Ditrame Plus, Abidjan, Coˆte
d’Ivoire.
Renaud Becquet, Didier Ekouevi, Ida Viho, Charlotte Sakarovitch, Hassan
Toure, Katia Castetbon, Nacoumba Coulibaly, Marguerite Timite-Konan,
Laurence Bequet, Franc¸ois Dabis, et al.
To cite this version:
Renaud Becquet, Didier Ekouevi, Ida Viho, Charlotte Sakarovitch, Hassan Toure, et al.. Ac-
ceptability of exclusive breast-feeding with early cessation to prevent HIV transmission through
breast milk, ANRS 1201/1202 Ditrame Plus, Abidjan, Coˆte d’Ivoire.. Journal of Acquired Im-
mune Deficiency Syndromes, Lippincott, Williams & Wilkins, 2005, 40 (5), pp.600-8. <inserm-
00189796>
HAL Id: inserm-00189796
http://www.hal.inserm.fr/inserm-00189796
Submitted on 13 Jun 2008
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.

JAIDS - J Acquir Immune Defic Syndr (in press) 
ANRS 1201/1202 Ditrame Plus          1 
Acceptability of exclusive breastfeeding with early cessation to prevent HIV 
transmission through breastmilk, ANRS 1201/1202 Ditrame Plus, Abidjan, Côte d'Ivoire 
 
Renaud BECQUET, MPH 
1
, Didier K. EKOUEVI, MD, PhD 
2
, Ida VIHO, MD 
2
, Charlotte 
SAKAROVITCH, MSc 
1
, Hassan TOURE, MD 
2
, Katia CASTETBON, PhD 
3
, Nacoumba 
COULIBALY, MD 
2
,   Marguerite TIMITE-KONAN,  MD 
4
, Laurence BEQUET, MD 
2
, 
François DABIS, MD, PhD 
1
, Valériane LEROY, MD, PhD 
1
, ANRS 1201/1202 Ditrame 
Plus Study Group 
 
1
 Unité INSERM 593, Institut de Santé Publique Epidémiologie Développement (ISPED), 
Université Victor Segalen, Bordeaux, France  
2
 Projet ANRS Ditrame Plus, Programme PAC-CI, Centre Hospitalier Universitaire de 
Treichville, Abidjan, Côte d'Ivoire  
3
 Unité de Surveillance et d'Epidémiologie Nutritionnelles, Institut national de la Veille 
Sanitaire (InVS),  Conservatoire National des Arts et Métiers, Paris, France  
4
 Service de pédiatrie, Centre Hospitalier Universitaire de Yopougon, Abidjan, Côte d'Ivoire  
 
Correspondence and reprint requests: Renaud BECQUET, Unité INSERM 593, Institut de 
Santé Publique Epidémiologie Développement, Université Victor Segalen Bordeaux 2, 146 
rue Léo Saignat, 33076 Bordeaux Cedex, France, Tel.: +33.(0)5.57.57.45.35,  Fax: 
+33.(0)5.57.57.45.28, E-mail: Renaud.Becquet@isped.u-bordeaux2.fr    
 
The primary sponsor of the ANRS 1201/1202 Ditrame Plus study was the Agence Nationale 
de Recherches sur le Sida (ANRS). Renaud BECQUET was a fellow of the French Ministry 
of Education, Research and Technology. Didier K. EKOUEVI was a fellow of the French 
charity "Ensemble contre le Sida". Laurence BEQUET was supported by the French Ministry 
of Foreign Affairs.  
 ANRS 1201/1202 Ditrame Plus          2 
 
ABSTRACT 
 
Objective: We assessed the uptake of a nutritional intervention promoting exclusive 
breastfeeding with early cessation between three and four months of age to reduce postnatal 
transmission of HIV in Abidjan, Côte d'Ivoire. 
Design: Between March 2001 and March 2003, HIV infected pregnant women who had 
received a perinatal antiretroviral prophylaxis were systematically offered prenatally two 
infant feeding interventions: either artificial feeding, or exclusive breastfeeding during three 
months then early cessation of breastfeeding. Mother-infant pairs were closely followed for a 
period of two years, with continuous nutritional counseling and detailed collection of feeding 
practices. 
Results: Among the 557 mothers enrolled, 262 (47%) initiated breastfeeding. Of these 
women, the probability of practicing exclusive breastfeeding from birth was 18% and 10% at 
one and three months of age, respectively. Complete cessation of breastfeeding was obtained 
in 45% and 63% by four and six months of age, respectively. Environmental factors such as 
living with partner's family were associated with failure to initiate early cessation of 
breastfeeding. 
Conclusions: Acceptability of exclusive breastfeeding was low in this urban population. 
However, shortening the duration of breastfeeding appeared to be feasible. Further 
investigations are ongoing to fully evaluate the safety and effectiveness of this intervention in 
reducing breastmilk HIV transmission. 
 
Keywords: HIV, Africa, mother-to-child transmission, infant feeding practices, exclusive 
breastfeeding, weaning  
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INTRODUCTION 
 
Mother-to-child transmission (MTCT) of human immunodeficiency virus type 1 (HIV) is 
responsible for most of the acquisition of pediatric HIV infections. Each day in the world, 
2,200 children become HIV-infected, 90% of them in sub-Saharan Africa where MTCT of 
HIV is an increasing public health problem 
1
. MTCT of HIV can occur in-utero, during 
delivery, or through breastfeeding. In settings where prolonged breastfeeding is the norm, 
breast milk transmission is responsible for one third to 40% of perinatally acquired HIV 
infections 
2
. The overall risk of postnatal transmission was estimated to be 8.9 new cases per 
100 child-years of breast-feeding (95% confidence interval [CI], 7.8–10.2) in a recent pooled 
analysis 
3
.  
The efficacy of short-course antiretroviral regimens to prevent HIV transmission around the 
time of delivery has been demonstrated in industrialized countries and in sub-Saharan Africa 
4, 5
. Nevertheless, in the absence of targeted intervention, the subsequent risk of postnatal 
transmission of HIV considerably reduces the long term efficacy of peripartum antiretroviral 
prophylaxis 
6
. Besides antiretroviral-based interventions to reduce the risk of postnatal HIV 
transmission 
7
, different nutritional approaches are conceivable in modifying infant feeding 
practices such as complete avoidance of breastfeeding in urban settings or shortening the 
breastfeeding period 
8
. Indeed in areas where breastfeeding is usually prolonged at least until 
12 months of age, this latter approach should reduce the cumulative risk of postnatal 
transmission while keeping the benefits of breastfeeding during the first months of life. 
Moreover, there is some observational evidence that exclusive breastfeeding carries a lower 
postnatal risk of transmission of HIV than breastfeeding with introduction of other fluids, 
feeds or milk 
9-11
. Indeed, contaminants or bacteria contained in these additional feeds may 
damage the infant's gut, impair mucosal integrity and thus facilitate postnatal transmission of 
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HIV 
12, 13
. Thus, the combined promotion of exclusivity of breastfeeding with early cessation 
may substantially reduce breastmilk HIV transmission.  
The evaluation of such postnatal nutritional interventions aimed at the prevention of mother-
to-child transmission of HIV (PMTCT) must be based on several judgment criteria beginning 
with the uptake of the intervention proposed, that can be itself divided into its prenatal 
acceptability and the long-term compliance.  
The objective of this study was to assess in an urban west African setting the uptake of an 
infant feeding strategy based on the promotion of exclusive breastfeeding with early cessation 
between three and four months of age in a cohort of HIV-infected women. 
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SUBJECTS AND METHODS 
 
Study area 
The ANRS 1201/1202 Ditrame Plus study was conducted in Abidjan, the economic capital of 
Côte d'Ivoire (3 million inhabitants). In this setting, municipal water of good quality was 
widely available but household water storage was a common practice, which may contribute 
to the contamination of drinking water 
14
.  
The study population was recruited in Abobo and Yopougon, the two most densely populated 
districts of Abidjan. HIV counseling and testing services were set up within the University 
Hospital of Yopougon and the antenatal clinics of six pre-existing community-run health 
facilities.  
 
Inclusion procedures  
From March 2001 to March 2003, any pregnant woman aged at least 18, attending one of the 
selected prenatal clinics and living within the limits of Abidjan, was offered pre-test-
counseling and HIV testing 
15
. Those women who tested positive were offered the opportunity 
to enter the study from 32 weeks of gestation after having had the objectives of the study 
explained to them,  having accepted the study protocol and signed an informed consent 
16
.  
 
Research design 
Within this open-labeled cohort, women received a short peripartum drug combination of 
zidovudine  +/- lamivudine and nevirapine single dose 
17
. Women who delivered a live-birth 
were systematically proposed post-partum nutritional interventions. 
At inclusion, pregnant women were informed about the modalities of post-natal transmission 
of HIV during a 30 minutes face-to-face counseling session, and were told that alternatives to 
prolonged and predominant breastfeeding may prevent this risk. The advantages of these 
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interventions, i.e. the reduction of the risk of HIV transmission through breastmilk, and their 
disadvantages, i.e. the possible stigmatization and the potential risks for infant health, were 
fully discussed with the participants.  
Two nutritional interventions were then hierarchically and systematically proposed to the 
women and discussed again during subsequent weekly prenatal visits scheduled until delivery. 
The first option consisted of the complete avoidance of breastfeeding: artificial feeding from 
birth free of charge to nine months of age with free provision of the material and using a 
single oral dose of cabergoline, whose efficacy to inhibit lactation in puerperal women has 
been demonstrated 
18
. The second option consisted of practicing exclusive breastfeeding with 
the aim to wean after a short period (not exceeding two weeks) and to obtain complete 
cessation of breastfeeding between three and four months of age. Women were encouraged to 
cup-feed their infants when initiating weaning. Replacement feeding until nine months of age 
as well as the material needed were provided free of charge. In all cases, the staff supported 
the choice expressed by the women and counseled them accordingly.  
 
Follow-up procedures 
Two clinics were exclusively dedicated to the enrolment and follow-up of the mother-infant 
pairs. A total of 60 health care workers recruited from the local area were employed for this 
study. 
From birth up to the second birthday, 19 visits were scheduled for clinical, nutritional, 
psychosocial and biological follow-up of both mothers and infants. Mother-infant pairs were 
seen at birth, 48 hours after delivery, weekly until six weeks of age, monthly until nine 
months of age, and every three months until the second birthday. Services dispensed by the 
study team were also available whenever needed between scheduled visits. All transport costs 
were reimbursed and all care expenses related to any scheduled visit or clinical event were 
entirely supported by the project. 
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Four nutritionists individually counseled the women about infant feeding practices whenever 
needed. Collective sessions were frequently organized to help mothers correctly position their 
baby to the breast, or to reiterate the benefits of exclusive breastfeeding, how to safely prepare 
artificial feeding, initiate weaning, use appropriate complementary feeding or cook the baby 
food. 
 
Diagnosis of peri-partum pediatric HIV infection 
Paediatric blood samples collected at day two and at four and six weeks of age were 
processed for plasma RNA viral load measurement by real time polymerase chain reaction 
using the quantitative Taqman technology allowing a diagnosis of peri-partum HIV infection 
17, 19
.  
 
Data collection 
At each contact, the medical staff documented clinical events that occurred in both mothers 
and children since the last visit. At each scheduled visit, infant feeding practices were 
recorded via structured questionnaires by trained social workers who were not involved in 
nutritional counseling. Women were asked if their child had been given breastmilk, artificial 
milk or both since the last visit. Fluids and foods other than breastmilk or artificial milk were 
documented using a 24 hour and a seven day recall history. Social workers went over a 
detailed list of 15 commonly used fluids or foods. Women were asked if these fluids, foods or 
some other items not listed had been given in the previous seven days, and if so in what 
amount (24 hour recall history) and how frequently in the past seven days. The first liquid 
given after birth was recorded at the day two visit.  
Infants were classified at each scheduled visit as exclusively or predominantly breastfed, 
mixed fed or artificial fed using these recall histories 
20
. Being exclusively breastfed from 
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birth at a given time meant having been classified in this category at all the preceding visits 
since birth. 
We used the following WHO definitions to allow a better comparability of results between 
studies. Exclusive breastfeeding means giving a child no other food or drink, including no 
water, in addition to breastfeeding with the exception of medicines, vitamin drops or syrups, 
and mineral supplements 
21
. Predominant breastfeeding means breastfeeding a child but also 
giving small amounts of water or water based drinks. Neither food-based fluid nor solid food 
are allowed under this definition 
21
. Artificial feeding means feeding a child on artificial foods 
(including infant formula and powdered animal milk), and not breastfeeding at all 
22
. Mixed 
feeding means breastfeeding while giving non-human milk such as infant formula or food-
based fluid or solid food 
23
. We defined a nutritional change as a switch from one of these 
categories to one another, and weaning process as the period from the introduction of the first 
weaning food till complete cessation of breastfeeding.  
 
Statistical analysis 
Women whose live-born infants were breastfed at least once were initially classified as 
breastfeeding at the day two visit and were included in the following analyses.  
The prenatal infant feeding choice was described among women who initiated breastfeeding.  
Infant feeding practices were presented in detail at one, three, four, six and nine months of age 
(M1, M3, M4, M6 and M9 respectively). For this purpose, we used a time varying 
classification according to the liquids and foods consumed over the past seven days before 
each of these visits, independently of what occurred before these visits.  
The probability of being exclusively breastfed from birth as well as the probabilities of 
initiating weaning and having completely ceased breastfeeding were estimated at given ages 
using the Kaplan-Meier technique.  
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We used two different definitions to investigate the proportion of women who successfully 
practiced the nutritional intervention proposed. Firstly, we defined success as breastfeeding 
the infant exclusively from birth until the beginning of weaning and having completely ceased 
breastfeeding between M3 and M4 (definition 1). Secondly, we defined success as complete 
breastfeeding cessation occurring between M3 and M4, irrespective of the exclusivity of 
breastfeeding (definition 2). As the assessment of the uptake was impossible among children 
who died or were lost to follow-up before the age of M4, while they were still being 
exclusively breastfed (definition 1), or exclusively or predominantly breastfed (definition 2) at 
their last contact, they were unclassified. Sensitivity analyses were performed to classify these 
cases as either success or failure to the intervention proposed. 
Baseline socio-demographic, clinical and biological maternal characteristics were compared 
between mothers who succeeded with the intervention and those who failed according to 
those two definitions of success.  
Logistic regression was used to assess the determinants of a complete cessation of 
breastfeeding occurring beyond the M3-M4 period (failure). Multivariate analysis included 
maternal baseline socio-demographic, biological and clinical characteristics and multivariate 
analysis included all variables with p<0.25 in the univariate analysis 
24
.  
All statistical analyses were carried out with the use of SAS software (version 8.2; SAS 
Institute, Inc, Cary, NC). 
  
 ANRS 1201/1202 Ditrame Plus          10 
RESULTS 
 
Recruitment and baseline characteristics 
As shown in figure 1, 643 HIV infected pregnant women were consecutively enrolled 
between March 2001 and March 2003. Sixty-three women with HIV-2 infection only or lost 
to follow-up prior to delivery were excluded from the analysis. Overall, 580 women gave 
birth, and after exclusion of stillbirth as well as second and third born babies of multiple birth 
outcomes, 569 mother-infant pairs were eligible for analysis. Among the 557 mothers whose 
livebirth was fed at least once, 262 (47%) initiated breastfeeding and constituted the 
breastfeeding group for the present analysis.  
Their baseline socio-demographic, clinical and biological characteristics as well as the 
delivery circumstances and their newborn characteristics are detailed in table 1. Overall, 47% 
were illiterate, and 70% were living with their partner, of whom a quarter had shared their 
HIV status with him before delivery. All but eight had electricity at home, all of them had 
access to tap water and 74% lived in a shared housing. Three quarters of the women included 
were at WHO clinical stage 1 or 2, the remaining at stage 3. Their baseline median CD4 count 
was 392 (IQR: 266-540) and their median viral load was 4.2 log (IQR: 3.6-4.7).  
 
Mother-infant pairs follow-up 
From birth until nine months of age, among the 262 mother-infant pairs analyzed, 34 (13%) 
were lost to follow-up at a median age of  51 days (IQR: 7-133) and 12 (4%) infants died. 
Among the remaining 216 mother-infant pairs, 197 (91%) completed the 15 visits scheduled 
from birth until nine months of age, the reminders completing 11 visits on average.  
 
Prenatal choice 
Among the 262 women initiating breastfeeding, 255 (97%) made their choice during the 
prenatal period on how to feed their forthcoming infant. Of these women, 227 (89%) intended 
 ANRS 1201/1202 Ditrame Plus          11 
to breastfeed, of whom 84 (37%) underlined they would exclusively breastfeed. Among the 
227 women wishing to breastfeed their infant, four (2%) considered ceasing breastfeeding 
before three months, 88 (39%) between three and four months, 60 (26%) after four months, 
and the remainder (33%) did not express an opinion antenatally. 
 
Initial infant feeding practice 
In this breastfeeding group (n=262), the first liquid given from birth was breastmilk (73%), 
tap water (9%), boiled or mineral water (4%), sugar water (1%), infant formula (3%), fruit 
juice (1%) and could not be documented for 9% of the women. Infant formula had been given 
by the staff of hospitals where women had been hospitalized for a caesarian section. In the 
first 48 hours of life, 160 (61%) children were predominantly breastfed, 90 (34%) exclusively 
breastfed and 12 (5%) mixed fed. 
Among the 84 mothers who had prenatally chosen to exclusively breastfeed their infant, 51% 
did so, whereas 75% of the 143 mothers who had prenatally chosen to predominantly 
breastfeed actually initiated this practice (p<0.001). 
 
Exclusivity of breastfeeding 
As shown in figure 2, at one and three months of age, the majority of infants had not been 
exclusively but predominantly breastfed the week before the interview (respectively 59% and 
62%) as they were also given water, essentially from a tap. Use of boiled or mineral water 
was relatively common at one month of age (30%). Most of the infants (39%) were mixed fed 
at four months of age, of whom 83% were in the process of being weaned and were thus 
receiving infant formula. From six months of age, most of the infants were not breastfed any 
more and received artificial feeding instead, while the remaining breastfed infants were 
essentially mixed fed as they also received baby food, other solid or semi solid foods such as 
dairy products, meat, fish, or all sorts of plants. 
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The cumulative probabilities of being exclusively breastfed from birth were 0.18 (95% CI: 
0.13-0.22), 0.10 (0.06-0.13) and 0.01 (0-0.02) at ages M1, M3 and M6 respectively (figure 3).  
 
Duration of breastfeeding 
Overall, 167 mothers (64%) had completely ceased breastfeeding before M9, 38 infants 
(14%) died or were lost to follow-up before reaching that age while they were still being 
breastfed at their last contact and 57 (22%) infants were still breastfed at M9.  
Overall, 24 women (9%) ceased breastfeeding before M3: 12 mothers were counseled by the 
medical and nutritional staff of the study to cease breastfeeding for maternal medical reasons 
(chickenpox, breast pathology, AIDS-related disease), child's disease (candidiasis), or 
breastmilk deficiency, and 12 mothers changed their mind and switched to artificially feed 
their infant. Altogether, 100 women (38%) completely ceased breastfeeding at M3-M4 as 
recommended. 
The cumulative probabilities of beginning the weaning process and having completely ceased 
breastfeeding are detailed in figure 4. The median age of infants at initiation of the weaning 
process was 97 days (IQR: 91-125) ; it was 106 days (IQR: 94-136) at complete cessation of 
breastfeeding. Complete cessation of breastfeeding was achieved for 94% of these infants 
after one endeavor of weaning. The weaning process was initiated with the introduction of 
infant formula to replace breastfeeding. At that time, 4% of the women preferred to be kept 
away from the child for a while and 2% used bandages to cover their breasts. None of the 
women reported to have used any repellent products to facilitate the weaning process. Women 
reported breast pain (33%), breast engorgement (18%), or baby tears (17%) related to the 
weaning process. Only 2% of the women reported partner or family disapproval to the early 
breastfeeding cessation. 
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Success of the intervention proposed  
Among the 262 mothers-infant pairs who had initiated breastfeeding, 4 (1%) infants died or 
were lost to follow-up before M4 while they were still being exclusively breastfed at their last 
contact. Only 14 (5%) succeeded in practicing exclusive breastfeeding until weaning in 
having completely ceased breastfeeding between M3 and M4, i.e. did it as planned in the 
protocol concerning the quality of breastfeeding and its duration .  
Women who failed to achieve this objective had in median fewer living children (1 vs. 3, 
p=0.01) and were at less advanced stages of HIV disease than those who succeeded (HIV-1 
RNA plasma viral load of 4.2 vs. 4.6, p=0.04).  
We then considered the second, less stringent definition of success. Among the 262 mother-
infant pairs who had initiated breastfeeding, 33 (13%) infants died or were lost to follow-up 
before M3 while they were still being breastfed at their last contact, irrespective of the 
exclusivity of the breastfeeding practice. Among the 229 mothers who could thus be 
classified, 24 (10%) ceased breastfeeding before M3, 100 (44%) between M3 and M4 and 105 
(46%) beyond M4.  
In an unadjusted analysis detailed in table 1, being followed in the clinic based in the district 
of Abobo, living in a typical shared housing and having delivered at home were associated 
with failure of the proposed intervention. Women who failed to practice the recommended 
intervention also had significantly higher CD4 count than those who succeeded.  
The results of the multivariate logistic regression model investigating the determinants of a 
complete cessation of breastfeeding occurring beyond the M3-M4 period (n=105 vs. n=100) 
are detailed in table 2. After adjustment, failure of the proposed intervention was significantly 
associated with being followed in the Abobo site, having a maternal CD4 count above 500 
and living with partner's family. Similar results were obtained when investigating the 
determinants of  a complete cessation of breastfeeding after vs. before M4 completed i.e. in 
pooling together women who ceased breastfeeding before M3 and in the M3-M4 period. 
 ANRS 1201/1202 Ditrame Plus          14 
DISCUSSION 
 
This study investigated in an urban African context the uptake of a nutritional intervention 
aimed at preventing HIV transmission through breastmilk. In this setting where predominant 
and prolonged breastfeeding is widely practiced 
6, 25
, HIV infected women were given a 
proposal to feed their infants in an unusual way compared to common local practice, as it 
consisted of implementing both exclusive breastfeeding and early cessation of breastfeeding 
from three months of age. Overall, the uptake of this combined intervention was low as only 
5% of the women strictly fed their infant as planned by the study protocol in terms of 
exclusivity and duration of breastfeeding. However, complete cessation of breastfeeding was 
obtained in 45% and 63% of the women at M4 and M6, respectively.   
 
The Ditrame Plus study was conducted among all attendees of community run health facilities 
located in poor areas, with no other selection criteria than being HIV infected, at least 18 
years old, and having accepted the study protocol. As a result, half of the women included 
were illiterate and three quarters of them lived in crowded typical accommodation, thus quite 
representative of the general population in Abidjan 
25
.  
This prospective study provided information on the evolution of infant feeding practices from 
birth until nine months of age in a Sub-Saharan African setting with a reasonably high level of 
precision. Indeed, emphasis was made on the collection of nutritional data with the use of 
standardized forms to perform the recall histories, the frequent visits scheduled over the 
follow-up period and interviews conducted by trained health care workers other than those 
who counseled the women on infant feeding practices. This minimized the maternal recall 
bias that could have impaired the estimation of the age of introduction of the liquids and foods 
and thus could have overestimated the duration of exclusive breastfeeding 
26, 27
.  
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Before the implementation of the Ditrame Plus study, we had performed within the same 
community-run health facilities a baseline cross-sectional study among women of unknown 
HIV status. We found that all mothers had given tap or stored water to their child in median 
one day after delivery, underlying that exclusive breastfeeding was not practiced in this 
population 
28
. Despite the efforts made on prenatal and postnatal counseling to promote 
exclusive breastfeeding within the Ditrame Plus study, the probability of being exclusively 
breastfed from birth remained as low as 10% at M3. The same low acceptability of exclusive 
breastfeeding had been previously reported within another prospective study conducted in 
rural South Africa where at M3 about 10% of children were exclusively breastfed from birth 
29
. However, in our study, the proportion of mixed fed children remained rather low in the 
first three months of life. The low uptake of exclusive breastfeeding was primarily the 
consequence of early introduction of other liquids than breastmilk rather than early 
introduction of infant formula or semi-solid foods. From four months of age, the study 
protocol implied a short period of mixed feeding (nine days in median), linked to the use of 
both infant formula and breastmilk during the weaning process, whose consequences in terms 
of postnatal transmission of HIV will be difficult to assess but are likely to be limited 
considering the briefness of the period. Beyond four months of age, infants who were still 
exposed to breastfeeding were essentially mixed fed. These long term breastfed infants would 
remain at risk of being HIV infected through breastmilk as the longer the breastfeeding 
continued, the higher the postnatal risk 
3
.  
 
Breastfeeding women included in the Ditrame Plus study failed to practice exclusive 
breastfeeding, but most of them succeeded in ceasing breastfeeding early, as the median age 
at complete cessation of breastfeeding was 4 months (IQR: 3-5).  Indeed, the median duration 
of breastfeeding was previously found to range from 8 months (IQR: 7-10) to 15 months 
(IQR: 13-18) within two different PMTCT studies conducted in Abidjan from 1995 to 2000 
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with no systematic counseling on infant feeding practices 
30-32
. Thus, our study provides 
useful knowledge underlining that shortening the duration of breastfeeding would be feasible 
in this population.  
Women who failed to cease breastfeeding before M4 were under the social pressure of the 
family of the partner (especially his mother) influencing the decision process about infant 
feeding practices. Moreover, living in crowded accommodation appeared to be linked with 
difficulties with early initiation of the weaning process. Prenatal sharing of HIV status with a 
relative tended to be associated with failure to cease breastfeeding early, but this factor never 
reached statistical significance, even after adjustment. These social factors must however be 
carefully taken into account when counseling mothers on infant feeding options, and 
emphasis should be made on issues regarding confidentiality. Women at more advanced 
stages of the disease were those who significantly ceased breastfeeding the earliest. They may 
have been too ill to be able to continue breastfeeding. Nevertheless, as these women also 
tended to practice more exclusive breastfeeding than the others, this is consistent with the fact 
that they could have decided to be more compliant to the nutritional intervention proposed. 
They might also have been urged by health care workers to do so, as we previously reported 
that the Ditrame Plus staff believed the choice of the feeding practice should be guided by the 
value of maternal CD4 count 
33
. Generally speaking, health care workers have a key role to 
play in reaching successful practices of alternatives to prolonged and predominant 
breastfeeding. Indeed, the fact that despite the adjustment on mothers' characteristics, failure 
to cease breastfeeding early was strongly associated with being followed in one of the two 
study sites rather than in the other one could underline differences on infant feeding 
counseling between the two sites. Indeed, this nutritional counseling remains difficult to 
standardize.  
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Acceptability of exclusive breastfeeding was extremely low in this population where early 
introduction of liquids is a common practice from birth. We thus strongly believe that new 
tools and innovative ways of counseling women on the importance of exclusive breastfeeding 
for infant health are needed to make the promotion of exclusive breastfeeding feasible in this 
context. However, shortening the duration of breastfeeding appeared to be feasible in this 
urban setting given appropriate counseling on infant feeding practices, a close nutritional and 
clinical follow up and the free provision of breastmilk substitutes from initiation of the 
weaning process up to nine months of age. To fully evaluate this complex nutritional 
intervention, these results will be balanced in the future with its potential benefits such as the 
reduction of postnatal transmission of HIV, as well as its potential risks for infant health, 
especially after early weaning (growth characteristics, severe morbidity, mortality) or linked 
to the mother (incidence of new pregnancies, stigmatization). 
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 Table 1. Baseline characteristics of mother-infant pairs according to the infant's age at complete cessation of breastfeeding, ANRS 1201/1202 Ditrame Plus 
study, Abidjan, Côte d'Ivoire (N=262) 
  Age at cessation of breastfeeding   p-value 
 
Overall 
(n=262) 
< M3 
(n=24) 
M3-M4 
(n=100) 
> M4 
(n=105) 
 
overall 
M3-M4  
vs. < M3  
M3-M4  
vs. > M4  
 
Maternal baseline socio-demographic characteristics N (%) N (%) N (%) N (%) 
 
  
 
 
Site          
Avocatier, district of Abobo 225 (86) 20 (83) 76 (76) 101 (96)  < 0.001 0.44 < 0.001 
Niangon, district of Yopougon 37 (14) 4 (17) 24 (24) 4 (4)     
Age at delivery (median, IQR)   26 (22-30) 22 (19-28) 26 (24-30) 26 (22-30)  0.05 0.01 0.50 
Education          
No schooling  123 (47) 11 (46) 43 (43) 49 (47)  0.62 0.90 0.36 
Primary school 89 (34) 7 (29) 34 (34) 40 (38)     
Secondary school or higher 50 (19) 6 (25) 23 (23) 16 (15)     
Lifestyle          
Lives alone 6 (2) 0 2 (2) 3 (3)  0.68 0.48 0.69 
Lives with her partner 183 (70) 12 (50) 72 (72) 78 (74)  0.06 0.04 0.71 
Lives with her family 104 (40) 15 (62) 36 (36) 39 (37)  0.05 0.02 0.87 
Lives with her partner's family 71 (27) 5 (21) 24 (24) 33 (31)  0.37 0.74 0.23 
Prenatal sharing of HIV status with partner when applicable 48 (26) 3 (12) 17 (17) 30 (29)  0.07 0.59 0.05 
At least one co-spouse  72 (27) 8 (33) 26 (26) 28 (27)  0.76 0.47 0.91 
Mother employed in formal economic sector 149 (53) 12 (50) 49 (49) 61 (58)  0.40 0.93 0.19 
Lives in a shared housing (cour commune) 
1
 193 (74) 14 (58) 70 (70) 84 (80)  0.06 0.27 0.09 
Electricity at home  254 (97) 23 (96) 95 (95) 104 (99)  0.23 0.86 0.09 
Main water supply          
Tap water with tap at home  61 (23) 7 (29) 23 (23) 21 (20)  0.61 0.53 0.60 
Tap water with tap outside home 201 (77)  17 (71) 77 (77) 84 (80)     
History of pregnancies (median, IQR) 3 (2-5) 3 (1-4) 4 (3-5) 3 (2-4)  0.16 0.11 0.13 
Number of children alive (median, IQR) 1 (0-2) 1 (0-2) 1 (0-2) 1 (0-2)  0.27 0.10 0.77 
 
1
 typical housing in Abidjan with several houses organized around a yard where inhabitants share kitchen and restroom, and live in crowded accommodation 
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Table 1 (continued).  
  Age at cessation of breastfeeding   p-value 
 
Overall 
(n=262) 
< M3 
(n=24) 
M3-M4 
(n=100) 
> M4 
(n=105) 
 
overall 
M3-M4  
vs. < M3  
M3-M4  
vs. > M4  
 
Maternal baseline biological and clinical characteristics N (%) N (%) N (%) N (%) 
 
  
 
 
Lymphocyte CD4+ count/mm
3
 (median, IQR) 392 (266-540) 321 (204-483) 381 (283-485) 406 (274-604)  0.06 0.17 0.13 
Lymphocyte CD4+ percentage (median, IQR) 26 (20-33) 24 (17-29) 26 (20-33) 27 (20-35)  0.13 0.16 0.36 
Log10 HIV-1 RNA plasma viral load (median, IQR) 4.2 (3.6-4.7) 4.4 (3.7-5.0) 4.1 (3.7-4.7) 4.3 (3.7-4.7)  0.42 0.27 0.37 
WHO clinical stage          
Stage 1 or 2 197 (75) 19 (79) 81 (81) 75 (71)  0.60 0.97 0.27 
Stage 3 65 (25) 5 (21) 19 (19) 30 (29)     
Stage 4/AIDS 0  0 0 0     
 
Delivery circumstances and newborn characteristics N (%) N (%) N (%) N (%) 
 
  
 
 
Home delivery  38 (15) 2 (8) 10 (10) 21 (20)  0.08 0.80 0.04 
Caesarean section  11 (4) 0 8 (8) 3 (3)  0.12 0.15 0.10 
Maternal complications following delivery  18 (7) 1 (4) 10 (10) 5 (5)  0.29 0.37 0.15 
Multiple birth outcome 10 (4) 4 (17) 3 (3) 2 (2)  < 0.001 0.001 0.61 
Female livebirths 124 (47) 11 (46) 48 (48) 59 (56)  0.42 0.85 0.24 
Birth weight, kg (median, IQR) 3.0 (2.7-3.2) 2.9 (2.5-3.2) 3.0 (2.7-3.2) 3.0 (2.7-3.2)  0.03 0.03 0.75 
Pediatric peri-partum HIV-infection 14 (5)  0 5 (5) 7 (7)  0.41 0.26 0.61 
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Table 2. Determinants of ceasing breastfeeding beyond the M3-M4 period (failure to the 
recommended practice), multivariate logistic regression, ANRS 1201/1202 Ditrame Plus 
study, Abidjan, Côte d'Ivoire (N=205). 
 
 Odds Ratio 95% CI p-value 
 
Abobo site vs. Yopougon site 
 
9.13 
 
2.90 - 28.82 
 
< 0.001 
Mother living with partner's family vs. not 1.99 1.01 - 3.93 0.04 
Prenatal sharing of HIV status with someone vs. 
not 
1.95 0.98 - 3.91 0.06 
Mother gainfully employed vs. not 1.69 0.91 - 3.14 0.10 
Mother living in a shared housing vs. not 1.46 0.71 - 2.97 0.30 
Electricity at home vs. not 7.19 0.78 - 66.37 0.08 
Maternal CD4 count at inclusion above 500 vs. 
below 
2.00 1.01 - 3.95 0.04 
Single birth outcome vs. multiple 2.82 0.41 - 19.46 0.29 
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LEGENDS FOR FIGURES 
 
Figure 1.  
Cohort profile according to the infant feeding options. ANRS 1201/1202 Ditrame Plus, 
Abidjan, Côte d'Ivoire  
 
Figure 2 
Infant feeding practices at ages M1, M3, M4, M6 and M9 in the breastfeeding group. ANRS 
1201/1202 Ditrame Plus, Abidjan, Côte d'Ivoire (N=262) 
 
Figure 3 
Kaplan-Meier probability of being exclusively breastfed from birth. ANRS 1201/1202 
Ditrame Plus, Abidjan, Côte d'Ivoire (N=262) 
 
Figure 4 
Kaplan-Meier probability of having initiated weaning and completely ceased breastfeeding . 
ANRS 1201/1202 Ditrame Plus, Abidjan, Côte d'Ivoire (N=262) 
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Figure 1 
 
 
initiation of formula feeding 
N=277  (52.4%)     N=35 (61.4%) 
lost to follow up before recording 
information on first feed 
N=1  (0.2%)               N=0  
died before first feed 
N=10  (1.8%)    N=3 (5.0%) 
stillbirths 
N=10  (1.8%)    N=2 (3.2%) 
Women enrolled: 643 
Women eligible for analysis: 624 
Women who gave birth: 580 
Single birth outcomes: 550 
Birth outcomes: 612 
Livebirths: 540 
Livebirths fed at least once: 
529 
Multiple birth outcomes: 62 
First born: 30 
Livebirths: 60 
First born: 29 
 
Livebirths fed at least once: 57 
First born: 28 
women excluded  
(HIV-2 infection only) 
N=19 (2.9%) 
women lost to follow-up  
before delivery 
N=44 (7.0%) 
Initiation of breastfeeding: 252 Initiation of breastfeeding: 22 
First born: 10 
Mother-infant pairs analysed: 262 
Breastfeeding group 
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Figure 2 
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Figure 3 
 
 
  
 
 
 
 
 
 
M1 M3 M4 M6 M9 
Probability of being  
exclusively breastfed 
0.18 0.10 0.03 0.01 0 
95% CI 0.13-0.22 0.06-0.13 0.01-0.05 0.00-0.02 - 
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Figure 4 
 
 
      
 
 
 
 
M1 M3 M4 M6 M9 
 
Probability of having initiated 
weaning 
0.08 0.19 0.54 0.71 0.79 
95% CI 0.05-0.11 0.14-0.24 0.48-0.60 0.65-0.77 0.74-0.85 
 
Probability of having ceased 
breastfeeding 
0.08 0.11 0.45 0.63 0.73 
95% CI 0.05-0.11 0.07-0.15 0.39-0.52 0.57-0.69 0.68-0.79 
 
 
 
 
 
 
